News and Trends 8 May 2017
The EU Approves New Treatment for a Rare Pediatric Cancer
…but targeting the anti-GD2 antibody is actually not new. US-based United Therapeutics‘ anti-GD2 antibody Unituxin was approved by the EMA for the treatment of neuroblastoma in patients aged 12 months…